Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Bracco UK, Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ-UK
Gastromiro.
| Pharmaceutical Form |
|---|
|
Gastromiro is an aqueous colourless to pale yellow solution for oral or rectal administration (enema). |
| Active component | Quantity per ml |
|---|---|
| iopamidol (I.N.N.) | 612.4 mg |
Iopamidol 61.24% w/v.
Excipient(s) with known effect: ethanol (2.4 mg per mL) – see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Iopamidol |
Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media. |
| List of Excipients |
|---|
|
Excipients – Quantity per ml: Orange flavour 2.2 mg |
The containers are amber glass bottles (Type III) with aluminium screw caps, guarantee seals, and elastomer inserts.
Boxes of 1 bottle 20ml.
Boxes of 1 bottle 50ml.
Boxes of 1 bottle 100ml.
Bracco UK, Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ-UK
PL 18920/0036
9 January 1991 / 9 January 1996
| Drug | Countries | |
|---|---|---|
| GASTROMIRO | Austria, Estonia, Ireland, United Kingdom |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
